European evidence based consensus on the diagnosis and management of Crohn’s disease: special situations

R Caprilli¹, M A Gassull², J C Escher³, G Moser⁴, P Munkholm⁵, A Forbes⁶, D W Hommes⁷, H Lochs⁸, E Angelucci⁹, A Cocco¹⁰, B Vucelic¹¹, H Hildebrand¹², S Kolacek¹³, L Riis¹⁴, M Lukas¹⁵, R de Franchis¹⁶, M Hamilton¹⁷, G Jantschek¹⁸, P Michetti¹⁹, C O’Morain²⁰, M M Anwar²⁰, J L Freitas²¹, I A Mouzas²², F Baert²³, R Mitchell²⁴, C J Hawkey²⁵ for the European Crohn’s and Colitis Organisation (ECCO)

¹ University of Rome "La Sapienza" Department of Clinical Sciences, Rome, Italy
² Department of Gastroenterology and Hepatology, Hospital Universitari Germans Trias i Pujol, Badalona, Spain
³ Erasmus MC-Sophia Children’s Hospital, University Medical Centre, Rotterdam, Netherlands
⁴ Department of Internal Medicine IV, University Hospital of Vienna, Vienna, Austria
⁵ Herlev Hospital, University of Copenhagen, Herlev, Denmark
⁶ University College Hospital, London, UK
⁷ Academic Medical Centre, Department of Gastroenterology and Hepatology, Amsterdam, Netherlands
⁸ Clinic of General, Visceral, Vascular and Thoracic Surgery, Charite Campus Mitte, Humboldt-University of Berlin, Berlin, Germany
⁹ University of Rome, GI Unit, Department of clinical science, La Sapienza, Policlinico Umberto I, Rome, Italy
¹⁰ Gastroenterology Unit, University of Rome La Sapienza, Rome, Italy
¹¹ University Hospital Rebro, Division of Gastroenterology and Hepatology, Zagreb
¹² Department of Women and Child Health, Astrid Lindgren Children’s Hospital, Stockholm, Sweden
¹³ University Children’s Hospital Zagreb, Department of Gastroenterology and Nutrition, Klaiceva, Croatia
¹⁴ Herlev Hospital, University of Copenhagen, Herlev, Denmark
¹⁵ IVth Medical Department, Charles University Hospital, Prague, Czech Republic
¹⁶ Instituto di Medicina Interna, Cattedra di Gastroenterologia Policlinico, Milan, Italy
¹⁷ Department of Gastroenterology, The Royal Free Hospital, London, UK
¹⁸ Stadtkrankenhaus Neuwied, Federal Republic of Germany
¹⁹ Centre Hospitalier Universitaire Vaudois, Division of Gastroenterology, Lausanne, Switzerland
²⁰ Adelaide and Meath Hospital, Department of Gastroenterology, Dublin
²¹ Department of Gastroenterology and Hepatology, Hospital Garcia de Orta, Almada, Portugal
²² Gastroenterology Department, University Hospital, Heraklion, Greece
²³ Heilig Hartziekenhuis, Roeselare, Belgium
²⁴ EFFCA, Bournemouth, Dorset UK
²⁵ Wolfson Digestive Disease Centres, University Hospital Nottingham, UK

Correspondence to:
Correspondence to:
Dr S P L Travis
John Radcliffe Hospital, Oxford OX3 9DU, UK; simon.travis{at}orh.nhs.uk; Professor E F Stange MD PhD, Professor of Medicine, Department of Internal Medicine 1, Robert Bosch Krankenhaus, PO Box 501120, Auerbachstr 110, 70341 Stuttgart, Germany; Eduard.Stange{at}rbk.de

This third section of the European Crohn’s and Colitis Organisation (ECCO) Consensus on the management of Crohn’s disease concerns postoperative recurrence, fistulating disease, paediatrics, pregnancy, psychosomatics, extraintestinal manifestations, and alternative therapy. The first section on definitions and diagnosis reports on the aims and methods of the consensus, as well as sections on diagnosis, pathology, and classification of Crohn’s disease. The second section on current management addresses treatment of active disease, maintenance of medically induced remission, and surgery of Crohn’s disease.

Keywords: Crohn’s disease; postoperative recurrence; fistula; paediatric; adolescence; pregnancy; psychosomatic; extraintestinal manifestation; complementary therapy

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Sokol, H, Polin, V, Lavergne-Slove, A, Panis, Y, Treton, X, Dray, X, Bouhnik, Y, Valleur, P, Marteau, P (2009). Plexitis as a predictive factor of early postoperative clinical recurrence in Crohn's disease. Gut 58: 1218-1225 [Abstract] [Full Text]  
• Horsthuis, K., Lavini, C., Bipat, S., Stokkers, P. C. F., Stoker, J. (2009). Perianal Crohn Disease: Evaluation of Dynamic Contrast-enhanced MR Imaging as an Indicator of Disease Activity. Radiology 251: 380-387 [Abstract] [Full Text]  
• Stange, E. F, Travis, S. P L (2008). The European consensus on ulcerative colitis: new horizons?. Gut 57: 1029-1031 [Full Text]  
• Ferguson, C. B, Mahsud-Dornan, S., Patterson, R N. (2008). Inflammatory bowel disease in pregnancy. BMJ 337: a427-a427 [Full Text]  
• Sorrentino, D., Terrosu, G., Avellini, C., Maiero, S. (2007). Infliximab With Low-Dose Methotrexate for Prevention of Postsurgical Recurrence of Ileocolonic Crohn Disease. Arch Intern Med 167: 1804-1807 [Full Text]